ACRS
Companies
NASDAQ
Aclaris Therapeutics Inc.
Health Care
$1.40
-$1.08 (-43.55%)
Price Chart
Overview
About ACRS
aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
Market Cap
$72.0M
Volume
1.1M
Avg. Volume
1.4M
P/E Ratio
-2.2672415
Dividend Yield
0.00%
Employees
76.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.63
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ACRS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$72.0M
Volume1.1M
P/E Ratio-2.27
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025